Regencell Bioscience Holdings Limited company logo
Regencell Bioscience Holdings Limited logo

RGC Cash and Cash Equivalents

Annual Cash & Cash Equivalents

$4.90M$3.06M-38.49%

Summary

Current Value
As of today, RGC annual cash & cash equivalents is $4.90M, down -38.49% on
Historical Performance
RGC annual cash & cash equivalents is down -70.17% over the past 3 years, and up +1165.37% over the past 5 years
All-Time High Comparison
RGC annual cash & cash equivalents is currently -70.17% below its historical high of $16.42M set on
3-Year Low Comparison
RGC annual cash & cash equivalents is at its 3-year low
Sector Comparison
RGC annual cash & cash equivalents is higher than 19.41% of companies in Healthcare sector

Cash and Cash Equivalents Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

RGC Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash & Cash Equivalents$4.90M-38.5%-70.2%+1165.4%+1912.7%
Quarterly Cash & Cash Equivalents-
Price$52.88+10000.0%+6920.7%
Annual Current Assets$4.90M-39.6%-70.2%+1166.9%+1915.1%
Annual Total Liabilities$895.30K+307.9%-4.5%-71.7%-57.0%
Annual Working Capital$4.24M-46.5%-73.3%+252.6%+330.6%
Annual Net Income-$3.58M+17.9%+52.8%-341.2%-816.7%

Cash and Cash Equivalents Highs

RGC Annual Cash & Cash Equivalents Highs Comparison
PeriodHighDateCurrent
3Y$16.42MN/A-70.2%
5Y$16.42M-70.2%
All$16.42M-70.2%

Cash and Cash Equivalents Lows

RGC Annual Cash & Cash Equivalents Lows Comparison
PeriodLowDateCurrent
3Y$4.90Mat low
5Y$59.40K+8144.1%
All$59.40K+8144.1%

Cash and Cash Equivalents History

YearValueChange
$4.90M-38.5%
$7.96M-31.2%
$11.56M-29.6%
$16.42M>+9,900.0%
YearValueChange
$59.40K-84.7%
$387.00K+59.1%
$243.30K-

FAQ

  • What is the current annual cash & cash equivalents of RGC?

    As of today, RGC annual cash & cash equivalents is $4.90M

  • What is 1-year change in RGC annual cash & cash equivalents?

    RGC annual cash & cash equivalents is down -38.49% year-over-year

  • What is 3-year change in RGC annual cash & cash equivalents?

    RGC annual cash & cash equivalents is down -70.17% over the past 3 years

  • How far is RGC annual cash & cash equivalents from its all-time high?

    RGC annual cash & cash equivalents is currently -70.17% below its historical high of $16.42M set on June 30, 2022

  • How does RGC annual cash & cash equivalents rank versus sector peers?

    RGC annual cash & cash equivalents is higher than 19.41% of companies in Healthcare sector

  • When is RGC next annual earnings release?

    The next annual earnings release for RGC is on

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

  1. RGC Official Website www.regencellbioscience.com
  2. RGC Profile on Yahoo Finance finance.yahoo.com/quote/RGC
  3. RGC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rgc